Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Str8Shuteron Dec 03, 2020 12:47am
103 Views
Post# 32024188

RE:Warrants

RE:WarrantsGood question.  StageZERO has issued warrants on a number of occasions in the past, with various exercise prices and expiry dates.  None of them had ever been publicly tradeable until June 29, 2020, when they closed a public offering with Echelon and Clarus that included the publicly tradeable warrants we all know fondly as SZLS.WT.

As far as I can tell, the soon-to-be issued warrants (including non-transferable broker warrants) will NOT be publicly tradeable.  So, I don't think that there should be any effect on SZLS.WT whatsoever.

Following is a key excerpt from the amended short form prospectus dated Oct. 19, 2020:

"There is currently no market through which the Warrants may be sold and purchasers may not be able to resell the Warrants purchased under this Prospectus. This may affect the pricing of the Warrants in the secondary market, the transparency and availability of trading prices, the liquidity of the securities, and the extent of issuer regulation. See “Risk Factors”.  "


I'm not a lawyer, but that's my two cents on matter.  GLTA!


brad129 wrote: To those more educated on the warrant side of things are the last round of warrants dropping in value because the new ones will be available for pennies to start with? If they have a strike price of $1.10 wouldn't they be the better value( depending what people can purchase them for)


<< Previous
Bullboard Posts
Next >>